Clinical Trial Results:
Extension to a multicenter, open label study to assess the safety and efficacy of 600 micrograms SOM230, administered subcutaneously, b.i.d. in patients with Cushing's disease
Summary
|
|
EudraCT number |
2004-002407-32 |
Trial protocol |
IT GB |
Global completion date |
08 Jul 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
29 Sep 2021
|
First version publication date |
27 Dec 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
CSOM230B2208E1 Full results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.